AstraZeneca jab guidance change for u...
Published
The Medicines and Healthcare products Regulatory Agency has said there is a possible link between the vaccine and ‘extremely rare’ blood clots.
Full ArticlePublished
The Medicines and Healthcare products Regulatory Agency has said there is a possible link between the vaccine and ‘extremely rare’ blood clots.
Full ArticleLONDON (AP) — The European Medicines Agency said Friday that people who have received a first dose of AstraZeneca's COVID-19..
The decision to offer the under-30s an alternative to the AstraZeneca vaccine over blood clotting concerns has had no impact on..